Extended half-life target module for sustainable UniCAR T-cell treatment of STn-expressing cancers
Adapter chimeric antigen receptor (CAR) approaches have emerged has promising strategies to increase clinical safety of CAR T-cell therapy. In the UniCAR system, the safety switch is controlled via a target mo...
Journal of Experimental & Clinical Cancer Research 2020 39:77


No hay comentarios:
Publicar un comentario